calendar
2,169 catalysts · 3,827 phase readout · 2,121 8k filing · 277 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
2,169 catalysts · 3,827 phase readout · 2,121 8k filing · 277 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 3.02, 9.01
Items: 2.02, 9.01
Items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 2.02, 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 8.01
Items: 2.02, 9.01
Items: 1.01
Items: 5.02
Items: 3.01
Items: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
Items: 3.01, 7.01, 9.01
Items: 8.01, 9.01
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 3.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.07
Items: 7.01, 9.01
Items: 5.02
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 3.01, 7.01, 9.01